tiprankstipranks
Affimed price target lowered to $1 from $2 at Stifel
The Fly

Affimed price target lowered to $1 from $2 at Stifel

Stifel lowered the firm’s price target on Affimed to $1 from $2 and keeps a Hold rating on the shares following the company’s Q4 update. Management reiterated plans for the AFM13+AB-101 IND submission in the first half and to start a trial in 2023, but questions remain around the trial’s approval, lead-in phase, and duration, said the firm, which adds that it doesn’t think the AFM24 phase 1 data planned for Q2 or Q3 will "emerge as a new stock driver."

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on AFMD:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles